Seibold, Frank Werner

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006

2015

Safroneeva, Ekaterina; Vavricka, S; Fournier, N; Seibold, Frank Werner; Mottet, C; Nydegger, A; Ezri, J; Straumann, A; Rogler, G; Schoepfer, A M; Juillerat, Pascal; Swiss IBD Cohort, Study Group (2015). Systematic analysis of factors associated with progression and regression of ulcerative colitis in 918 patients. Alimentary pharmacology & therapeutics, 42(5), pp. 540-548. Wiley-Blackwell 10.1111/apt.13307

Vavricka, Stephan R; Rogler, Gerhard; Gantenbein, Claudine; Spoerri, Muriel; Prinz Vavricka, Mareike; Navarini, Alexander A; French, Lars E; Safroneeva, Ekaterina; Fournier, Nicolas; Straumann, Alex; Froehlich, Florian; Fried, Michael; Michetti, Pierre; Seibold, Frank Werner; Lakatos, Peter L; Peyrin-Biroulet, Laurent; Schoepfer, Alain M (2015). Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort. Inflammatory bowel diseases, 21(8), pp. 1794-1800. Lippincott Williams & Wilkins 10.1097/MIB.0000000000000429

Juillerat, Pascal; Peter, M; Macpherson, James; Slack, Emma; Patuto, Nicola; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (February 2015). Measurement of functional blocade of TNF-alpha by anti-TNF agents is a stronger predictor than trough levels and anti-drug antibodies: 2-year prospective clinical data (Unpublished). In: European Crohn’s and colitis organization congress (ECCO). Barcelona. Februar 2015.

Juillerat, Pascal; Andrew, Peter; Macpherson, James; Slack, Emma; Seibold, Frank Werner; Cahenzli, Julia; McCoy, Kathleen; Macpherson, Andrew (2015). Measurement of functional blocade of TNF-alpha by anti-TNF agents is a stronger predictor than trough levels and anti-drug antibodies: 2-year prospective clinical data. Gastroenterology, 148(4), pp. 850-1. Elsevier

2014

Schaffer, Thomas; Schoepfer, Alain M; Seibold, Frank Werner; Juillerat, Pascal; Swiss Inflammatory Bowel Diseases Cohort Study Group, The (2014). Serum ficolin-2 correlates worse than fecal calprotectin and CRP with endoscopic Crohn's disease activity. Journal of Crohn's & Colitis, 8(9), pp. 1125-1132. Oxford University Press 10.1016/j.crohns.2014.02.014

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (May 2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Gastroenterology, 146(5), p. 239. Elsevier

Cleynen, I.; Vazeille, E.; Artieda, M.; Verspaget, H. W.; Szczypiorska, M.; Bringer, M.-A.; Lakatos, P. L.; Seibold, Frank Werner; Parnell, K.; Weersma, R. K.; Mahachie John, J. M.; Morgan-Walsh, R.; Staelens, D.; Arijs, I.; De Hertogh, G.; Müller, Stefan Jürg; Tordai, A.; Hommes, D. W.; Ahmad, T.; Wijmenga, C.; ... (2014). Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease. Gut, 63(8), pp. 1265-1274. BMJ Publishing Group 10.1136/gutjnl-2012-303205

Protic, Marijana; Seibold, Frank Werner; Schöpfer, Alain; Radojicic, Zoran; Juillerat, Pascal; Bojic, Daniela; Mwinyi, Jessica; Mottet, Christian; Jojic, Njegica; Beglinger, Christoph; Vavricka, Stephan; Rogler, Gerhard; Frei, Pascal (2014). The effectiveness and safety of rescue treatments in 108 patients with steroid-refractory ulcerative colitis with sequential rescue therapies in a subgroup of patients. Journal of Crohn's & Colitis, 8(11), pp. 1427-1437. Elsevier 10.1016/j.crohns.2014.05.004

Sauter, Bernhard; Beglinger, Christoph; Girardin, Marc; Macpherson, Andrew; Michetti, Pierre; Schoepfer, Alain; Seibold, Frank Werner; Vavricka, Stephan R; Rogler, Gerhard (2014). Monitoring disease activity and progression in Crohn's disease. A Swiss perspective on the IBD ahead 'optimised monitoring' recommendations. Digestion, 89(4), pp. 299-309. Karger 10.1159/000360283

Juillerat, Pascal; Andrew, Peter Michael; Macpherson, James; Slack, Emma; Cahenzli, Julia; Seibold, Frank Werner; McCoy, Kathleen; Macpherson, Andrew (2014). CD62L (L-Selectin) Shedding for Assessment of Functional Blockade of TNF-Alpha in Anti-TNF treated Inflammatory Bowel Disease Patients: Clinical Feasibility and Perspectives. Swiss medical weekly, 144(Suppl206), 3S-3S. EMH Schweizerischer �rzteverlag

2013

Siebert, Uwe; Wurm, Johannes; Gothe, Raffaella Matteucci; Arvandi, Marjan; Vavricka, Stephan R.; von Känel, Roland; Begré, Stefan; Sulz, Michael C.; Meyenberger, Christa; Sagmeister, Markus; Müller, Christoph; Seibold, Frank Werner; the Swiss IBD Cohort Study Group, (Müller C) (2013). Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: results of the swiss inflammatory bowel disease cohort study. Inflammatory bowel diseases, 19(4), pp. 847-855. Lippincott Williams & Wilkins 10.1097/MIB.0b013e31827f278e

Seibold, Frank Werner (2013). PPI: Sicher oder doch nicht? Zu wenig oder doch zu häufig verschrieben? Ars medici - Schweizer Zeitschrift für Hausarztmedizin, 4, p. 205. Rosenfluh

Schaffer, Thomas; Flogerzi, Beatrice; Schoepfer, Alain M; Seibold, Frank; Müller, Stefan (2013). Increased titers of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients with reduced H-ficolin levels but normal MASP-2 activity. Journal of Crohn's & Colitis, 7(1), e1-10. Amsterdam: Elsevier

Vavricka, Stephan R.; Manser, Christine N.; Hediger, Sebastian; Vögelin, Marius; Scharl, Michael; Biedermann, Luc; Rogler, Sebastian; Seibold, Frank Werner; Sanderink, René; Attin, Thomas; Schoepfer, Alain; Fried, Michael; Rogler, Gerhard; Frei, Pascal (2013). Periodontitis and Gingivitis in Inflammatory Bowel Disease. Inflammatory bowel diseases, 19(13), pp. 2768-2777. Lippincott Williams & Wilkins 10.1097/01.MIB.0000438356.84263.3b

2012

Biedermann, Luc; Rogler, Gerhard; Vavricka, Stephan R; Seibold, Frank; Seirafi, Mariam (2012). Pregnancy and breastfeeding in inflammatory bowel disease. Digestion, 86 Suppl 1, pp. 45-54. Basel: Karger 10.1159/000341941

Jostins, Luke; Ripke, Stephan; Weersma, Rinse K; Duerr, Richard H; McGovern, Dermot P; Hui, Ken Y; Lee, James C; Schumm, L Philip; Sharma, Yashoda; Anderson, Carl A; Essers, Jonah; Mitrovic, Mitja; Ning, Kaida; Cleynen, Isabelle; Theatre, Emilie; Spain, Sarah L; Raychaudhuri, Soumya; Goyette, Philippe; Wei, Zhi; Abraham, Clara; ... (2012). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature, 491(7422), pp. 119-24. London: Macmillan Journals Ltd. 10.1038/nature11582

Seibold, F; Münger, C (2012). Durchblutungsstörungen im Abdomen. Informierte Arzt, pp. 45-47. Erlenbach (CH): Aerzteverlag medinfo AG

2011

Lottaz, Daniel; Maurer, Christoph A; Noël, Agnès; Blacher, Silvia; Huguenin, Maya; Nievergelt, Alexandra; Niggli, Verena; Kern, Alexander; Müller, Stefan; Seibold, Frank; Friess, Helmut; Becker-Pauly, Christoph; Stöcker, Walter; Sterchi, Erwin E (2011). Enhanced activity of meprin-?, a pro-migratory and pro-angiogenic protease, in colorectal cancer. PLoS ONE, 6(11), e26450. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0026450

Rogler, G; Beglinger, C; Mottet, C; Seibold, F; Gross, V (2011). [Topical therapy of ulcerative colitis]. Praxis - schweizerische Rundschau für Medizin, 100(23), pp. 1413-24. Bern: Huber 10.1024/1661-8157/a000722

Manz, Michael; Michetti, Pierre; Seibold, Frank; Rogler, Gerhard; Beglinger, Christoph (2011). Treatment algorithm for moderate to severe ulcerative colitis. Swiss medical weekly, 141, w13235. Muttenz: EMH Schweizerischer Ärzteverlag 10.4414/smw.2011.13235

Vavricka, Stephan R; Schoepfer, Alain M; Bansky, Georg; Binek, Janek; Felley, Christian; Geyer, Martin; Manz, Michael; Rogler, Gerhard; de Saussure, Philippe; Sauter, Bernhard; Scharl, Michael; Seibold, Frank; Straumann, Alex; Michetti, Pierre; Swiss IBDnet, (2011). Efficacy and safety of certolizumab pegol in an unselected crohn's disease population: 26-week data of the FACTS II survey. Inflammatory bowel diseases, 17(7), pp. 1530-9. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.21521

Anderson, Carl A; Boucher, Gabrielle; Lees, Charlie W; Franke, Andre; D'Amato, Mauro; Taylor, Kent D; Lee, James C; Goyette, Philippe; Imielinski, Marcin; Latiano, Anna; Lagacé, Caroline; Scott, Regan; Amininejad, Leila; Bumpstead, Suzannah; Baidoo, Leonard; Baldassano, Robert N; Barclay, Murray; Bayless, Theodore M; Brand, Stephan; Büning, Carsten; ... (2011). Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nature genetics, 43(3), pp. 246-52. New York, N.Y.: Nature America 10.1038/ng.764

Rossin, Elizabeth J.; Lage, Kasper; Raychaudhuri, Soumya; Xavier, Ramnik J.; Tatar, Diana; Seibold, Frank Werner; Benita, Yair; Cotsapas, Chris; Daly, Mark J.; International Inflammatory Bowel Disease Genetics, Constortium (2011). Proteins encoded in genomic regions associated with immune-mediated disease physically interact and suggest underlying biology. PLoS genetics, 7(1), e1001273. San Francisco, Calif.: Public Library of Science 10.1371/journal.pgen.1001273

Rivas, Manuel A; Beaudoin, Mélissa; Gardet, Agnes; Stevens, Christine; Sharma, Yashoda; Zhang, Clarence K; Boucher, Gabrielle; Ripke, Stephan; Ellinghaus, David; Burtt, Noel; Fennell, Tim; Kirby, Andrew; Latiano, Anna; Goyette, Philippe; Green, Todd; Halfvarson, Jonas; Haritunians, Talin; Korn, Joshua M; Kuruvilla, Finny; Lagacé, Caroline; ... (2011). Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nature genetics, 43(11), pp. 1066-73. New York, N.Y.: Nature America 10.1038/ng.952

Seibold, F (2011). Eisenmangel: Ein häufiges Problem bei Patienten mit chronisch entzündlichen Darmerkrankungen. SMCCV Info, 73(9) Aarau: Schweizerische Morbus Crohn / Colitis ulcerosa Vereinigung SMCCV

2010

Schoepfer, Alain M.; Vavricka, Stephan R.; Binek, Janek; Felley, Christian; Geyer, Martin; Manz, Michael; Rogler, Gerhard; de Saussure, Philippe; Sauter, Bernhard; Seibold, Frank; Straumann, Alex; Michetti, Pierre (2010). Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohnʼs disease population. Inflammatory bowel diseases, 16(6), pp. 933-938. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.21127

Schoepfer, Alain M; Beglinger, Christoph; Straumann, Alex; Trummler, Michael; Vavricka, Stephan R; Bruegger, Lukas E; Seibold, Frank (2010). Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI. American journal of gastroenterology, 105(1), pp. 162-9. New York, N.Y.: Nature 10.1038/ajg.2009.545

Franke, Andre; McGovern, Dermot P B; Barrett, Jeffrey C; Wang, Kai; Radford-Smith, Graham L; Ahmad, Tariq; Lees, Charlie W; Balschun, Tobias; Lee, James; Roberts, Rebecca; Anderson, Carl A; Bis, Joshua C; Bumpstead, Suzanne; Ellinghaus, David; Festen, Eleonora M; Georges, Michel; Green, Todd; Haritunians, Talin; Jostins, Luke; Latiano, Anna; ... (2010). Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nature genetics, 42(12), pp. 1118-25. New York, N.Y.: Nature America 10.1038/ng.717

Juillerat, Pascal; Pittet, Valérie; Vader, John-Paul; Burnand, Bernard; Gonvers, Jean-Jacques; de Saussure, Philippe; Mottet, Christian; Seibold, Frank; Rogler, Gerhard; Sagmeister, Markus; Felley, Christian; Michetti, Pierre; Froehlich, Florian; Swiss Cohort Study, (2010). Infliximab for Crohn's disease in the Swiss IBD Cohort Study: clinical management and appropriateness. European journal of gastroenterology & hepatology, 22(11), pp. 1352-7. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/MEG.0b013e32833eaa8a

Pittet, V; Juillerat, P; Michetti, P; Vader, J-P; Burnand, B; Rogler, G; Beglinger, C; Seibold, F; Mottet, C; Felley, C; Gonvers, J-J; Froehlich, F; Swiss Cohort Study, (2010). Appropriateness of therapy for fistulizing Crohn's disease: findings from a national inflammatory bowel disease cohort. Alimentary pharmacology & therapeutics, 32(8), pp. 1007-16. Oxford: Wiley-Blackwell 10.1111/j.1365-2036.2010.04434.x

Müller, Stefan; Schaffer, Thomas; Flogerzi, Beatrice; Seibold-Schmid, Beatrice; Schnider, Jasmin; Takahashi, Kazue; Darfeuille-Michaud, Arlette; Vazeille, Emilie; Schoepfer, Alain M; Seibold, Frank (2010). Mannan-binding lectin deficiency results in unusual antibody production and excessive experimental colitis in response to mannose-expressing mild gut pathogens. Gut, 59(11), pp. 1493-500. London: BMJ Publishing Group 10.1136/gut.2010.208348

Velavan, T P; Boldt, Angelica B W; Tomiuk, Jürgen; Seibold, Frank; Schoepfer, Alain M; Flogerzi, Beatrice; Müller, Stefan; Abad-Grau, María Del Mar; Kremsner, Peter G; Kun, Jürgen F J (2010). Variant alleles of the mannose binding lectin 2 gene (MBL2) confer heterozygote advantage within Crohn's families. Scandinavian journal of gastroenterology, 45(9), pp. 1129-30. London: Informa Healthcare 10.3109/00365521.2010.485324

Dignass, AU; Eriksson, A; Kilander, A; Pukitis, A; Rhodes, JM; Varicka, S; Collaborators Lochs, H; Porst, H; von Boyen, G; Seibold, F; Emmrich, J (2010). Clinical trial: five or ten cycles of granulocyte-monocyte apheresis show equivalent efficacy and safety in ulcerative colitis. Alimentary pharmacology & therapeutics, 12(Jun;31), pp. 1286-95. Oxford: Wiley-Blackwell 10.1111/j.1365-2036.2010.04295.x

2009

Seibold, Frank; Schoepfer, Alain M (2009). Can fecal calprotectin or lactoferrin identify postoperative recurrence in Crohn's disease? Inflammatory bowel diseases, 16(10), pp. 1814-1815. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.21173

Schoepfer, Alain M; Flogerzi, Beatrice; Seibold-Schmid, Beatrice; Schaffer, Thomas; Kun, Jürgen F J; Pittet, Valerie; Mueller, Stefan; Seibold, Frank (2009). Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA). American journal of gastroenterology, 104(10), pp. 2508-16. New York, N.Y.: Nature 10.1038/ajg.2009.315

Banerjee, S; Oneda, B; Yap, L M; Jewell, D P; Matters, G L; Fitzpatrick, L R; Seibold, F; Sterchi, E E; Ahmad, T; Lottaz, D; Bond, J S (2009). MEP1A allele for meprin A metalloprotease is a susceptibility gene for inflammatory bowel disease. Mucosal immunology, 2(3), pp. 220-31. New York, N.Y.: Nature Publishing Group 10.1038/mi.2009.3

Schoepfer, Alain M; Schaffer, Thomas; Mueller, Stefan; Flogerzi, Beatrice; Vassella, Erik; Seibold-Schmid, Beatrice; Seibold, Frank (2009). Phenotypic associations of Crohn's disease with antibodies to flagellins A4-Fla2 and Fla-X, ASCA, p-ANCA, PAB, and NOD2 mutations in a Swiss Cohort. Inflammatory bowel diseases, 15(9), pp. 1358-67. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20892

Seibold, Frank Werner (2009). Abdominalschmerzen Editorial. Medical journal TMJ - Schweizer Zeitschrift für Innere Medizin, 1(3) Neuhausen (CH): Rosenfluh

Seibold, F; Gschossmann, J (2009). Pathophysiologische Betrachtungen zu Unterschieden und Gemeinsamkeiten. Medical journal TMJ - Schweizer Zeitschrift für Innere Medizin Neuhausen (CH): Rosenfluh

Schoepfer, AM; Beglinger, C; Straumann, A; Trummler, M; Renzulli, P; Seibold, F (2009). Correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes. Inflammatory bowel diseases, 15(12), pp. 1851-1858. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20986

Gschossmann, J; Seibold, F (2009). IBS und IBD: aktuelle Therapie. Medical journal TMJ - Schweizer Zeitschrift für Innere Medizin, 1, pp. 29-31. Neuhausen (CH): Rosenfluh

2008

Schoepfer, A; Trummler, M; Seeholzer, P; Seibold-Schmid, B; Seibold, F (2008). Discriminating IBD from IBS: Comparison of the test performance of fecal markers, blood leukocytes, CRP, and IBD antibodies. Inflammatory bowel diseases, 14(1), pp. 32-39. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20275

Schoepfer, Alain M; Flogerzi, Beatrice; Fallegger, Silvia; Schaffer, Thomas; Mueller, Stefan; Nicod, Laurent; Seibold, Frank (2008). Comparison of interferon-gamma release assay versus tuberculin skin test for tuberculosis screening in inflammatory bowel disease. American journal of gastroenterology, 103(11), pp. 2799-806. New York, N.Y.: Nature 10.1111/j.1572-0241.2008.02050.x

Müller, Stefan; Schaffer, Thomas; Schoepfer, Alain M; Hilty, Annamarie; Bodmer, Thomas; Seibold, Frank (2008). Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease. World journal of gastroenterology, 14(23), pp. 3650-61. Beijing (China): WJG Press 10.3748/wjg.14.3650

Schoepfer, A M; Schaffer, T; Seibold-Schmid, B; Müller, S; Seibold, F (2008). Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterology and motility, 20(10), pp. 1110-8. Oxford: Blackwell Science 10.1111/j.1365-2982.2008.01166.x

Schoepfer, A M; Gschossmann, J; Scheurer, U; Seibold, F; Straumann, A (2008). Esophageal strictures in adult eosinophilic esophagitis: dilation is an effective and safe alternative after failure of topical corticosteroids. Endoscopy, 40(2), pp. 161-4. Stuttgart: Thieme 10.1055/s-2007-995345

Beglinger, C; Binek, J; Braegger, C; Michetti, P; Rogler, G; Sauter, B; Seibold, F; Straumann, A (2008). Infliximab Monotherapie versus Kombinationstherapie mit Immunmodulatoren. Medical journal TMJ - Schweizer Zeitschrift für Innere Medizin(1), pp. 32-33. Neuhausen (CH): Rosenfluh

Seibold, F (2008). Editorial zur Antikörpertherapie bei IBD. Medical journal TMJ - Schweizer Zeitschrift für Innere Medizin(1), p. 3. Neuhausen (CH): Rosenfluh

Seibold, F (2008). What is the optimal maintenance treatment for Crohn's disease. Inflammatory bowel diseases, 14(14), S255-S256. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20672

Seibold, F; Schoepfer, A; Kaindl, G (2008). Clinical efficacy of infliximab and its effect on ability to work in a Bern IBD cohort. In: Jahreskongress SGG / SGCV.

2007

Schoepfer, AM; Trummler, M; Seeholzer, P; Criblez, D; Seibold, F (2007). Accuracy of Four Fecal Assays in the Diagnosis of Colitis. Diseases of the colon & rectum, 50(10), pp. 1697-1706. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1007/s10350-007-0303-9

Schaffer, T; Mueller, S; Flogerzi, B; Seibold-Schmid, B; Schoepfer, A; Seibold, F (2007). Anti-Saccharomyces cerevisiae antibodies in Crohn's patients crossreact with mannan from other yeast strains, and murine ASCA IgM can be experimentally induced with Candida albicans. Inflammatory bowel diseases, 13(11), pp. 1339-1346. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20228

Seibold, F; Boldt, AB; Seibold-Schmid, B; Schoepfer, AM; Flogerzi, B; Mueller, S; Kun, JF (2007). Association of deficiency for mannan-binding lectin with anti-mannan antibodies in Crohn's disease: A family study. Inflammatory bowel diseases, 13(9), pp. 1077-1082. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20156

Seibold, F; Boldt, AB; Seibold-Schmid, B; Schoepfer, AM; Flogerzi, B; Mueller, S; Kun, JF (2007). Deficiency for mannan-binding lectin is associated with antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their relatives. Gut, 56(1), p. 152. London: BMJ Publishing Group 10.1136/gut.2006.110007

Schaffer, T; Mueller, S; Schoepfer, AM; Hilty, A; Bodmer, T; Seibold, F (2007). Association of anti-mycobacterial IgG with antibodies against the yeast Saccharomyces cerevisiae in patients with Crohns's disease. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl 38), 8S. Basel: EMH Editores Medicorum Helveticorum

Schoepfer, AM; Gschossmann, J; Scheurer, U; Seibold, F; Straumann, A (2007). Esophageal strictures in Eosinophilic Esophagitis: Dilation is an Effective and Safe Therapeutic Alternative after Failure of Topical Corticosteroids. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl. 38), 6S. Basel: EMH Editores Medicorum Helveticorum

Schoepfer, AM; Flogerzi, B; Fallegger, S; Schaffer, T; Mueller, S; Nicod, L; Seibold, F (2007). Use of Interferon-gamma Release Assay for the Diagnosis of Latent Infection with Mycobacterium Tuberculosis in Inflammatory Bowel Disease. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl. 38), 5S. Basel: EMH Editores Medicorum Helveticorum

Schoepfer, AM; Trummler, M; Seeholzer, P; Seibold-Schmid, B; Seibold, F (2007). Discriminating IBD from IBS: a Comparative Evaluation of the Test Performance of Fecal Markers and IBD Antibodies. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl. 38), 5S. Basel: EMH Editores Medicorum Helveticorum

Schoepfer, AM; Schaffer, T; Seibold-Schmid, B; Mueller, S; Seibold, F (2007). Elevated antibodies against Flagellin support the concept of low-grade Mucosal Inflammation in Irritable Bowel Syndrome. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 7(Suppl. 38), 4S. Basel: EMH Editores Medicorum Helveticorum

Schoepfer, AM; Schaffer, T; Seibold-Schmid, B; Mueller, S; Seibold, F (2007). Elevated Antibodies against Flagellin support the Concept of Low Grade Mucosal Inflammation in Irritable Bowel Syndrome. Gastroenterology Philadelphia, Pa.: Elsevier

Schoepfer, AM; Mueller, S; Criblez, D; Schaffer, T; Seibold, F (2007). Circulating Levels of Leptin, Adiponectin and Alpha-MSH in Crohn's Disease Patients differ from a Matched Population. Journal of Crohn's & Colitis(1), AO03. Amsterdam: Elsevier

Schenk, Mirjam; Bouchon, Axel; Seibold, Frank; Mueller, Christoph (2007). TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. Journal of clinical investigation, 117(10), pp. 3097-106. Ann Arbor, Mich.: American Society for Clinical Investigation 10.1172/JCI30602

Schoepfer, AM; Gschossmann, J; Seibold, F; Scheurer, U; Straumann, A (2007). Esophageal Strictures in Eosinophilic Esophagitis: Dilation is an effective and safe Alternative after Failure of topical Corticosteroids. Journal of Crohn's & Colitis(1), AP14. Amsterdam: Elsevier

Schoepfer, AM; Trummler, M; Seeholzer, P; Seibold-Schmid, B; Seibold, F (2007). Biomarkers for Discrimination of IBD versus IBS: Accuracy of Fecal Leucocyte Markers is improved when combined with IBD Antibody Panels. Journal of Crohn's & Colitis(1), AP13. Amsterdam: Elsevier

Brunner, B; Scheurer, U; Seibold, F (2007). Differences in yeast intolerance between patients with Crohn's disease and ulcerative colitis. Diseases of the colon & rectum, 50(1), pp. 83-88. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1007/s10350-006-0749-1

Schüpbach, W; Vadday, K; Schaller, A; Brekenfeld, C; Kappeler, L; Benoist, JF; Xuan-Huong, C; Burgunder, J; Seibold, F; Gallati, S; Mattle, H (2007). Mitochondrial neurogastrointestinal encephalomyopathy in three siblings: clinical, genetic and neuroradiological features. Journal of neurology, 254(2), pp. 146-53. Heidelberg: Springer-Medizin-Verlag 10.1007/s00415-006-0255-3

Konrad, A; Lehrke, M; Schachinger, V; Seibold, F; Stark, R; Ochsenkühn, T; Parhofer, K; Göke, B; Broedl, U (2007). Resistin is an inflammatory marker of inflammatory bowel disease in humans. European journal of gastroenterology & hepatology, 19(12), pp. 1070-1074. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/MEG.0b013e3282f16251

Lehrke, M; Konrad, A; Schachinger, V; Tillack, C; Seibold, F; Stark, R; Parhofer, KG; Broedl, UC (2007). CXCL 16 is a surrogate marker of inflammatory bowel disease. Scandinavian journal of gastroenterology, 43(3), pp. 283-288. London: Informa Healthcare 10.1080/00365520701679249

Beglinger, C; Dudler, J; Mottet, C; Nicod, L; Seibold, F; Villiger, P; Zellweger, J (2007). Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy. Swiss medical weekly(137), 620-2 A. Muttenz: EMH Schweizerischer Ärzteverlag

Seibold, F (2007). Therapie gastroenterologischer Infektionen. Medical journal TMJ, p. 1. Neuhausen (CH): Rosenfluh

Seibold, F (2007). Irritable Bowel Syndrome. Volkserkrankung IBS ist ein Reizthema. Hausarztpraxis - Fortschritte der Medizin(Special), pp. 9-12. Zürich: Prime Public Media AG

Seibold, F; Schöpfer, A (2007). Therapie der Colitis ulcerosa. Ars medici - Schweizer Zeitschrift für Hausarztmedizin(VI), pp. 1-2. Neuhausen (CH): Rosenfluh

Seibold, F (2007). Volkserkrankung IBS ist ein Reizthema. Hausarztpraxis - Fortschritte der Medizin(Special), pp. 9-12. Zürich: Prime Public Media AG

2006

Luckschander, Nicole; Allenspach, Karin; Hall, Jean; Seibold, Frank; Gröne, Andrea; Doherr, Marcus G; Gaschen, Frédéric (2006). Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diarrheic dogs with food responsive disease or inflammatory bowel disease. Journal of veterinary internal medicine, 20(2), pp. 221-7. Oxford: Wiley-Blackwell 10.1892/0891-6640(2006)20[221:PACAAR]2.0.CO;2

Müller, Stefan; Schaffer, Thomas; Flogerzi, Beatrice; Fleetwood, Andrew; Weimann, Rosemarie; Schoepfer, Alain M; Seibold, Frank (2006). Galectin-3 modulates T cell activity and is reduced in the inflamed intestinal epithelium in IBD. Inflammatory bowel diseases, 12(7), pp. 588-97. Hagerstown, Md.: Lippincott Williams & Wilkins

Müller, Stefan; Arni, Stephan; Varga, Lajos; Balsiger, Bruno; Hersberger, Martin; Maly, Friedrich; Seibold, Frank (2006). Serological and DNA-based evaluation of Chlamydia pneumoniae infection in inflammatory bowel disease. European journal of gastroenterology & hepatology, 18(8), pp. 889-94. Hagerstown, Md.: Lippincott Williams & Wilkins

Bauerfeind, P; Beglinger, C; Beltinger, J; Braegger, C; Eigenmann, F; Fried, M; Guyot, J; Hürlimann, R; Michetti, P; Seibold, F; Straumann, A (2006). Infliximab - Recommendations practiques pour le traitment de la maladie de Crohn. Revue médicale suisse, 2(74), pp. 1807-15. Genève: Médecine & Hygiène

Broedl, UC; Schachinger, V; Lingenhel, A; Lehrke, M; Stark, R; Seibold, F; Goke, B; Kronenberg, F; Parhofer, KG; Konrad-Zerna, A (2006). Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease. Inflammatory bowel diseases, 13(4), pp. 391-397. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1002/ibd.20078

Schoepfer, A; Seibold, F (2006). Kolorektales Karzinom: Screening und Diagnostik. Medical journal TMJ - Schweizer Zeitschrift für Innere Medizin(1), pp. 18-9. Neuhausen (CH): Rosenfluh

Schoepfer, AM; Seibold, F (2006). Aktuelle Therapie der Colitis ulcerosa. Medical journal TMJ - Schweizer Zeitschrift für Innere Medizin(3), pp. 10-11. Neuhausen (CH): Rosenfluh

Schöpfer, A; Bielecki, J; Seibold, F; Giezendanner, S; Balsiger, B; Greeve, J; Christian, E; Weimann, R; Netzer, P; Scheurer, U; Gschossmann, JM (2006). Zweiwöchige Argon-Plasma-Koagulation als sichere und effektive Behandlungsoption für blutende hyperplastische Riesenpolypen bei einer Patientin mit Wassermelonenmagen und Leberzirrhose. Endoskopie heute(19), p. 52. Stuttgart: Thieme

Mueller, S; Flogerzi, B; Schaffer, T; Fleetwood, A; Schoepfer, A; Seibold, F (2006). Non T-cell derived Galectin-3 is immunoregulatory and is reduced in the inflamed intestinal epithelium in IBD. Gastroenterology, 130/(Suppl 33), A3616/A37. Philadelphia, Pa.: Elsevier

Schaffer, T; Müller, S; Seibold, F (2006). Mechanisms of anti-Saccharomyces cerevisiae antibody development in Crohn's Disease. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 6:(Suppl 33) Basel: EMH Editores Medicorum Helveticorum

Schoepfer, AM; Schaffer, T; Seibold-Schmid, B; Mueller, S; Seibold, F (2006). Antibodies to Flagellin: Clinical significance in Inflammatory bowel disease. American journal of gastroenterology(1101), A1158. New York, N.Y.: Nature

Schoepfer, A; Trummler, M; Seibold, B; Seeholzer, P; Seibold, F (2006). Accuracy of four fecal markers in inflammatory colonic disease. Poster präsentiert am DDW Los Angeles Mai 2006. Gastroenterology(130), A217. Philadelphia, Pa.: Elsevier

Schoepfer, A; Trummler, M; Seibold, B; Seeholzer, P; Seibold, F (2006). Diagnosis of Inflammatory Bowel Disease: which Laboratory Parameter helps the most? Gastroenterology(130), A208. Philadelphia, Pa.: Elsevier

Provide Feedback